Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chiò, A.
Right arrow Articles by Restagno, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chiò, A.
Right arrow Articles by Restagno, G.
Related Collections
Right arrow Amyotrophic lateral sclerosis
Right arrow All epidemiology
Right arrow Prevalence studies
Right arrow All Genetics
NEUROLOGY 2008;70:533-537
© 2008 American Academy of Neurology

Prevalence of SOD1 mutations in the Italian ALS population

A. Chiò, MD, B. J. Traynor, MD, F. Lombardo, PhD, M. Fimognari, PhD, A. Calvo, MD, P. Ghiglione, MD, R. Mutani, MD and G. Restagno, MD

From the ALS Center (A. Chiò, A. Calvo, P.G., R.M.), Department of Neuroscience, University of Torino, Italy; Section on Developmental Genetic Epidemiology (B.J.T.), National Institute of Mental Health, National Institutes of Health, Bethesda, MD; and Molecular Diagnosis and Genetic Counseling Unit (F.L., M.F., G.R.), Children's Hospital, ASO OIRMS Anna, Torino.

Address correspondence and reprint requests to Dr. Adriano Chiò, ALS Center, Department of Neuroscience, University of Torino, Via Cherasco 15, Torino 10126, Italy achio{at}usa.net

Background: Five to 10% of amyotrophic lateral sclerosis (ALS) cases are reported to be familial (FALS), and mutations of SOD1 account for 20% of these cases. However, estimates of SOD1 mutation prevalence have been exclusively based on case series and clinic referral cohorts.

Objective: To assess the frequency and nature of SOD1 mutations in a large population-based cohort of Italian patients diagnosed with ALS over a 6-year period.

Methods: All ALS cases incident in Piemonte and Valle d'Aosta, Italy, are collected through a prospective epidemiologic register. Almost all patients with ALS resident in the largest province of Piemonte (Turin) have been evaluated for SOD1 mutations in the 6-year period 2000 through 2005.

Results: During the study period, 386 residents of Turin province were diagnosed with ALS (mean crude incidence rate of 2.9/100,000/year). Twenty-two patients (5.7%) had a positive family history of ALS. SOD1 analysis was performed in 325 patients (84.2% of the whole cohort), including all FALS cases. Five patients carried a SOD1 coding mutation, three with a family history of ALS (13.6% of FALS) and two in sporadic cases (0.7% of sporadic ALS).

Conclusions: In this population-based series, the frequency of familial amyotrophic lateral sclerosis (FALS) was lower than that reported in series from ALS referral centers. While the frequency of SOD1 mutations in FALS was similar to the data reported in the literature, only 0.7% of sporadic ALS cases had a SOD1 mutation. Our data indicate that studies from referral centers may overestimate the frequency of FALS and of SOD1 mutations in sporadic ALS.

GLOSSARY: ALS = amyotrophic lateral sclerosis; FALS = familial ALS; SALS = sporadic ALS.


Supplemental data at www.neurology.org

Supported by grants from Compagnia San Paolo, Torino, Italy, and Progetti Finalizzati Regione Piemonte, 2003 and 2004.

Disclosure: The authors report no conflicts of interest.

Received July 6, 2007. Accepted in final form August 31, 2007.




This article has been cited by other articles:


Home page
PNHome page
K Murray and R J Davenport
A rapidly progressive neuropathy
Practical Neurology, June 1, 2009; 9(3): 172 - 175.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
A. Chio, J. C. Schymick, G. Restagno, S. W. Scholz, F. Lombardo, S.-L. Lai, G. Mora, H.-C. Fung, A. Britton, S. Arepalli, et al.
A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis
Hum. Mol. Genet., April 15, 2009; 18(8): 1524 - 1532.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Chio, G. Mora, A. Calvo, L. Mazzini, E. Bottacchi, R. Mutani, and On behalf of the PARALS
Epidemiology of ALS in Italy: A 10-year prospective population-based study
Neurology, February 24, 2009; 72(8): 725 - 731.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.